← FDA Drug Approvals (Drugs@FDA)

ABACAVIR SULFATE AND LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2025-04-16

Drug application

FDA Application #

ANDA205412

Application type

Abbreviated New Drug Application (Generic)

Brand name

ABACAVIR SULFATE AND LAMIVUDINE

Generic name

ABACAVIR AND LAMIVUDINE

Active ingredients

ABACAVIR SULFATE; LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD V

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2025-04-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown